The role of mesh technology with tumor prosthesis reconstruction to reconstruct the extensor mechanism of knee joint after resection of proximal tibial tumors
Abstract:Purpose
The aim of this study was to evaluate the role of mesh technique in the reconstruction of the extensor mechanism after resection of proximal tibial tumors.
Methods
We retrospectively analyzed the cases of 14 patients who were diagnosed with proximal tibial tumors at our center and reconstructed with tumor prosthesis, gastrocnemius muscle, and mesh between 2012 and 2017. The treatment strategies for patellar tendon reconstruction primarily involve gastrocnemius r… Show more
“…Complications include non-oncological ones such as infections, allograft resorption, soft tissue failure, and so on. In our experience, in case of massive defects formed after tumor removal, the most effective method of surgery is modular endoprosthetic replacement, which allows to perform ablastic tumor removal and in the shortest possible time to activate patients for their limb function restoration [2,4,9,11,20].…”
Section: Discussionmentioning
confidence: 99%
“…The proximal tibia (PT) is one of the most common sites for primary malignant bone tumors [1,3]. In this segment of skeleton, we observed up to 15 % of all osteosarcomas, 11 % of Ewing's sarcomas and 6 % of chondrosarcomas [5,6,11,15,27]. By the end of 1970s, above-knee amputation was the standard treatment procedure for PT malignant tumors [7,10,[14][15][16].…”
mentioning
confidence: 99%
“…Today, thanks to advances in radiological diagnostics, immunohistochemical studies, radical changes in general principles of treatment for primary malignant bone neoplasms, complex chemotherapy and improvement of surgeries it has changed. For example, technical modernization of endoprosthesis structures, organ-preserving surgery has become a standard method of treatment [1,2,5,6,8,9,11,15,16,27,28]. PT modular tumor endoprosthetic replacement is difficult to perform due to changeability of anatomical structure -there is a risk of injury of tibial nerve and popliteal vessels.…”
mentioning
confidence: 99%
“…PT modular tumor endoprosthetic replacement is difficult to perform due to changeability of anatomical structure -there is a risk of injury of tibial nerve and popliteal vessels. Moreover, together with a complex surgical performance, there are problems with closing the defect with soft tissues [2][3][4][5][6][7]9,[11][12][13]15]. For these reasons, the reconstruction of PT after tumor removal is associated with a large number of complications compared to other parts of the skeleton -from 40 to 70 % according to different authors [3,4,7,8,10,13,14,16,21,22,24-28].…”
mentioning
confidence: 99%
“…These include infections, structural disorders, aseptic instability, local recurrence, and a number of soft tissue lesions [3,8,11,[17][18][19][20][21][22][23][24][25][26]. To further standardize complications, E. R. Henderson et al [8] proposed a classification that was adopted in 2014 by the International Society of Limb Salvage (ISOLS).…”
The major method of malignant bone tumors treatment is surgery. The most important task of an orthopedic surgeon is to preserve an adjacent joint. Currently, there are a large number of various reconstructive surgeries, including structural bone allograft, allocomposite and modular endoprosthetics replacement.
The aim: to analyze the results of surgical treatment for proximal tibia malignant tumors using modular endoprosthesis.
Materials and methods. The results of proximal tibia (PT) modular endoprosthetic replacement in 48 patients with PT tumor lesions were evaluated. The patients were divided into two groups: I (n = 36) – tumor resection and primary modular endoprosthesis, II (n = 12) – revision modular endoprosthetic replacement due to complications. Complications were divided into oncological, mechanical and non-mechanical. The functional outcomes were measured using the MSTS and TESS scores.
Results. During the treatment, 10 (21.2 %) patients underwent myofascioplastic amputation at the middle third of the thigh: due to periprosthetic infection – 8 people and tumor recurrence – 2.
It was found that the patients got back to regular way of life on average in 2.0–2.5 months. Functional results on the MSTS score were 73 ± 12 %, on the TESS score – 74 ± 16 %, which corresponds to good functional results. Among the patients, who underwent limb salvage surgery, no tumor recurrence was detected during a follow-up period from 6 months up to 11 years.
Conclusions. The choice of surgical treatment depends on the size of tumor, its location, pathohistomorphological picture, age, presence of pathological fractures, vascular and nerve tumor invasion. The use of modern designs of PT modular tumor endoprostheses and perfect surgeries makes it possible to minimize complications.
“…Complications include non-oncological ones such as infections, allograft resorption, soft tissue failure, and so on. In our experience, in case of massive defects formed after tumor removal, the most effective method of surgery is modular endoprosthetic replacement, which allows to perform ablastic tumor removal and in the shortest possible time to activate patients for their limb function restoration [2,4,9,11,20].…”
Section: Discussionmentioning
confidence: 99%
“…The proximal tibia (PT) is one of the most common sites for primary malignant bone tumors [1,3]. In this segment of skeleton, we observed up to 15 % of all osteosarcomas, 11 % of Ewing's sarcomas and 6 % of chondrosarcomas [5,6,11,15,27]. By the end of 1970s, above-knee amputation was the standard treatment procedure for PT malignant tumors [7,10,[14][15][16].…”
mentioning
confidence: 99%
“…Today, thanks to advances in radiological diagnostics, immunohistochemical studies, radical changes in general principles of treatment for primary malignant bone neoplasms, complex chemotherapy and improvement of surgeries it has changed. For example, technical modernization of endoprosthesis structures, organ-preserving surgery has become a standard method of treatment [1,2,5,6,8,9,11,15,16,27,28]. PT modular tumor endoprosthetic replacement is difficult to perform due to changeability of anatomical structure -there is a risk of injury of tibial nerve and popliteal vessels.…”
mentioning
confidence: 99%
“…PT modular tumor endoprosthetic replacement is difficult to perform due to changeability of anatomical structure -there is a risk of injury of tibial nerve and popliteal vessels. Moreover, together with a complex surgical performance, there are problems with closing the defect with soft tissues [2][3][4][5][6][7]9,[11][12][13]15]. For these reasons, the reconstruction of PT after tumor removal is associated with a large number of complications compared to other parts of the skeleton -from 40 to 70 % according to different authors [3,4,7,8,10,13,14,16,21,22,24-28].…”
mentioning
confidence: 99%
“…These include infections, structural disorders, aseptic instability, local recurrence, and a number of soft tissue lesions [3,8,11,[17][18][19][20][21][22][23][24][25][26]. To further standardize complications, E. R. Henderson et al [8] proposed a classification that was adopted in 2014 by the International Society of Limb Salvage (ISOLS).…”
The major method of malignant bone tumors treatment is surgery. The most important task of an orthopedic surgeon is to preserve an adjacent joint. Currently, there are a large number of various reconstructive surgeries, including structural bone allograft, allocomposite and modular endoprosthetics replacement.
The aim: to analyze the results of surgical treatment for proximal tibia malignant tumors using modular endoprosthesis.
Materials and methods. The results of proximal tibia (PT) modular endoprosthetic replacement in 48 patients with PT tumor lesions were evaluated. The patients were divided into two groups: I (n = 36) – tumor resection and primary modular endoprosthesis, II (n = 12) – revision modular endoprosthetic replacement due to complications. Complications were divided into oncological, mechanical and non-mechanical. The functional outcomes were measured using the MSTS and TESS scores.
Results. During the treatment, 10 (21.2 %) patients underwent myofascioplastic amputation at the middle third of the thigh: due to periprosthetic infection – 8 people and tumor recurrence – 2.
It was found that the patients got back to regular way of life on average in 2.0–2.5 months. Functional results on the MSTS score were 73 ± 12 %, on the TESS score – 74 ± 16 %, which corresponds to good functional results. Among the patients, who underwent limb salvage surgery, no tumor recurrence was detected during a follow-up period from 6 months up to 11 years.
Conclusions. The choice of surgical treatment depends on the size of tumor, its location, pathohistomorphological picture, age, presence of pathological fractures, vascular and nerve tumor invasion. The use of modern designs of PT modular tumor endoprostheses and perfect surgeries makes it possible to minimize complications.
BackgroundEndoprostheses (EPC) are often utilized for reconstruction of the proximal humerus with either hemiarthroplasty (HA) or reverse arthroplasty (RA) constructs. RA constructs have improved outcomes in patients with primary lesions, but no studies have compared techniques in metastatic disease. The aim of this study is to compare functional outcomes and complications between HA and RA constructs in patients undergoing endoprosthetic reconstruction for proximal humerus metastases.MethodsWe retrospectively reviewed our institutional arthroplasty database to identify 66 (56% male; 38 HA and 28 RA) patients with a proximal humerus reconstruction for a non‐primary malignancy. The majority (88%) presented with pathologic fracture, and the most common diagnosis was renal cell carcinoma (48%).ResultssPatients with RA reconstructions had better postoperative forward elevation (74° vs. 32°, p < 0.01) and higher functional outcome scores. HA patients had more complications (odds ratio 13, p < 0.01), with instability being the most common complication.ConclusionsPatients with nonprimary malignancies of the proximal humerus had improved functional outcomes and fewer complications after undergoing reconstruction with a reverse EPC compared to a HA EPC. Preference for reverse EPC should be given in patients with good prognosis and ability to complete postoperative rehabilitation.
PurposeThe purpose of the study was to assess the outcomes of extensor mechanism reconstruction with proximal tibia‐patellar tendon composite allograft.
Methods24 consecutive patients treated with allograft‐prosthetic composite for proximal tibia tumour resection and a conventional total knee arthroplasty were included. Extensor mechanism reconstruction was performed with a proximal tibia‐patellar tendon composite allograft and the suture of the donor tendon to the remnant native patellar tendon. Function was evaluated by the Musculoskeletal Tumor Society score (MSTS) and range of motion. Western Ontario and MacMaster University (WOMAC) and visual analogue scale for pain also were used.
ResultsAfter a mean follow‐up of 11.7 (range 3–15) years, mean MSTS score was 22.4 (range 20–30), mean flexion was 94.0° (range 84°–110°), and mean extension lag was 7.2° (range 0°–18°). The mean VAS‐pain was 4.3 (range 2–6), and WOMAC score was 72.4 (range 58–100). There was no failure of the reconstructed extensor mechanism.
ConclusionPatellar tendon reconstruction with allogeneic tissue from the proximal tibia allograft sutured to the recipient’s remnant patellar tendon provides the mechanical support needed for healing of the reconstructed extensor mechanism with a substantial functional benefit to stabilize active knee extension and successful reconstruction survival at long‐term.
Level of evidenceIII.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.